PharmaTher Provides Update for Expected FDA Approval of Ketamine - Yahoo Finance
PHRRF Stock | USD 0.17 0.01 5.56% |
Roughly 62% of Pharmather Holdings' investor base is looking to short. The analysis of current outlook of investing in Pharmather Holdings suggests that many traders are alarmed regarding Pharmather Holdings' prospects. The current market sentiment, together with Pharmather Holdings' historical and current headlines, can help investors time the market. In addition, many technical investors use Pharmather Holdings stock news signals to limit their universe of possible portfolio assets.
Pharmather Holdings otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Pharmather daily returns and investor perception about the current price of Pharmather Holdings as well as its diversification or hedging effects on your existing portfolios.
Pharmather |
PharmaTher Provides Update for Expected FDA Approval of Ketamine Yahoo Finance
Read at news.google.com
Pharmather Holdings Fundamental Analysis
We analyze Pharmather Holdings' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmather Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmather Holdings based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Pharmather Holdings is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Pharmather Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharmather Holdings otc stock to make a market-neutral strategy. Peer analysis of Pharmather Holdings could also be used in its relative valuation, which is a method of valuing Pharmather Holdings by comparing valuation metrics with similar companies.
Peers
Pharmather Holdings Related Equities
FBIO | Fortress Biotech | 7.98 | ||||
ADIL | Adial Pharmaceuticals | 7.00 | ||||
ADTX | Aditxt | 5.71 | ||||
LUMO | Lumos Pharma | 1.86 | ||||
XOMAO | XOMA | 0.39 | ||||
CKPT | Checkpoint Therapeutics | 1.82 | ||||
GHRS | GH Research | 2.80 | ||||
RVPH | Reviva Pharmaceuticals | 3.23 | ||||
ATXI | Avenue Therapeutics | 9.77 | ||||
RNAZ | Transcode Therapeutics | 20.00 |
Complementary Tools for Pharmather OTC Stock analysis
When running Pharmather Holdings' price analysis, check to measure Pharmather Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmather Holdings is operating at the current time. Most of Pharmather Holdings' value examination focuses on studying past and present price action to predict the probability of Pharmather Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmather Holdings' price. Additionally, you may evaluate how the addition of Pharmather Holdings to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |